SCHEMBL8037293

SCHEMBL8037293

CCOC(=O)c1c(C)nc(-c2ccc(Cl)cc2)nc1OCC1(C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
KDM4E B2RXH2 5/20 0.46
RAB9A P51151 3/20 0.46
HSD17B10 Q99714 2/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 3/20 0.44
CYP1A2 P05177 1/20 0.44
TARBP2 Q15633 1/20 0.43
ALDH1A1 P00352 4/20 0.43
NPC1 O15118 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PKM P14618 1/20 0.43
TSHR P16473 4/20 0.43
MAPT P10636 3/20 0.42
CACNB4 O00305 2/20 0.41
CACNA1A O00555 2/20 0.41
CACNA1G O43497 2/20 0.41
CACNG3 O60359 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4008878 0.88 KDM4E (0.45) LMNAKDM4ERAB9AHSD17B10TP53
SCHEMBL8034254 0.88 LMNA (0.42) LMNARAB9ATP53POLBCYP1A2
SCHEMBL8030988 0.86 KDM4E (0.53) LMNAKDM4ERAB9AHSD17B10TP53
SCHEMBL8021662 0.83 KDM4E (0.50) LMNAKDM4ERAB9AHSD17B10TP53
SCHEMBL8031451 0.82 KDM4E (0.46) LMNAKDM4ERAB9AHSD17B10TP53
SCHEMBL8024872 0.81 KDM4E (0.48) LMNAKDM4ERAB9AHSD17B10TP53
SCHEMBL8040695 0.80 CNR1 (0.46) LMNAKDM4ERAB9AHSD17B10TP53
SCHEMBL4008882 0.80 KCNH2 (0.39) KDM4ERAB9AHSD17B10POLBCYP1A2
SCHEMBL8037202 0.80 KDM4E (0.46) LMNAKDM4ERAB9AHSD17B10TP53
SCHEMBL8034096 0.79 KDM4E (0.50) LMNAKDM4ERAB9AHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080248-A1 SUBSTITUTED 2-PHENYLPYRIMIDINE-5-CARBOXYLIC ACIDS AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed